| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/08/1998 | EP0833638A1 USE OF IMIDAZO 1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS |
| 04/08/1998 | EP0833626A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 04/08/1998 | EP0833624A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0680488B1 2,6-diaminopurine derivatives |
| 04/08/1998 | CN1178469A Treatment of cerebral ischemia and cerebral damage with neuroprotective agent |
| 04/08/1998 | CN1178467A Polyphenol fractions of tea, the use thereof and formulations containing same |
| 04/07/1998 | US5736564 Endothelin receptor antagonists |
| 04/07/1998 | US5736562 Modify function of serotonin in mammals |
| 04/07/1998 | US5736561 Vascular hypertrophy suppressor |
| 04/07/1998 | US5736555 Hypotensive agents; fda orange book listed patent for azilsartan medoxomil |
| 04/07/1998 | US5736554 Treating and/or preventing cardiovascular disorders |
| 04/07/1998 | US5736548 Cyclic guanosine 3*,5*-monophosphate phosphodiesterase inhibitors; treating heart failure, hypertension |
| 04/07/1998 | US5736535 1-pyrimidinylacetamide compounds which are inhibitors of human leukocyte elastase |
| 04/07/1998 | US5736528 N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists |
| 04/07/1998 | US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence |
| 04/07/1998 | US5736157 Parenterally administering a therapeutically effective amount of a lipid acceptor |
| 04/07/1998 | US5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/07/1998 | CA2130116C Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/07/1998 | CA2116785C Sustained release organic nitrite therapy |
| 04/02/1998 | WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 04/02/1998 | WO1998013366A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 04/02/1998 | WO1998013357A1 Benzo[1,4]thiazine derivatives and drugs comprising the same |
| 04/02/1998 | WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 04/02/1998 | WO1998013350A1 Qinoline derivatives inhibiting the effect of growth factors such as vegf |
| 04/02/1998 | WO1998013349A2 Heteroaryloxyethylamines as 5-ht1a ligands |
| 04/02/1998 | WO1998013337A1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 04/02/1998 | WO1998013061A1 Inhibition of 26s and 20s proteasome by indanones |
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 04/02/1998 | WO1998013053A1 Mistletoe (viscum) extracts |
| 04/02/1998 | WO1998013036A1 Pharmaceutical compositions comprising s-alkylisothiouronium derivatives |
| 04/02/1998 | WO1998013034A1 Use of sibutramine analogues to lower lipid levels |
| 04/02/1998 | WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor |
| 04/02/1998 | DE19639375A1 Mistel-Trockenextrakte Mistletoe dried extracts |
| 04/02/1998 | CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 04/02/1998 | CA2263479A1 Quinoline derivatives inhibiting the effect of growth factors such as vegf |
| 04/01/1998 | EP0832883A1 Tetrahydrobenzo(a)fluorene compounds and methods of use |
| 04/01/1998 | EP0832882A2 Naphthofluorene compounds, intermediates, compositions, and methods |
| 04/01/1998 | EP0832880A1 Dihydrobenzofluorene compounds, intermediates, compositions, and methods |
| 04/01/1998 | EP0832879A1 Process for preparing intermediates for thrombin inhibitors |
| 04/01/1998 | EP0832652A1 Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition |
| 04/01/1998 | EP0832232A1 Kunitz type plasma kallikrein inhibitors |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832126A1 G-protein receptor htnad29 |
| 04/01/1998 | EP0832125A1 Human g-protein receptor hgber32 |
| 04/01/1998 | EP0832102A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa |
| 04/01/1998 | EP0832085A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 04/01/1998 | EP0832082A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 04/01/1998 | EP0832079A1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 04/01/1998 | EP0832077A1 Improved isoxazoline fibrinogen receptor antagonists |
| 04/01/1998 | EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 04/01/1998 | EP0832075A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides |
| 04/01/1998 | EP0832074A1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists |
| 04/01/1998 | EP0832069A1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION |
| 04/01/1998 | EP0832066A1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 04/01/1998 | EP0832061A1 Benzamide derivatives and their use as vasopressin antagonists |
| 04/01/1998 | EP0831911A2 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 04/01/1998 | EP0831910A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 04/01/1998 | EP0831903A1 Connective tissue growth factor |
| 04/01/1998 | EP0831902A1 Muscle trophic factor |
| 04/01/1998 | EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent |
| 04/01/1998 | EP0831881A1 Method for increasing hdl cholesterol level |
| 04/01/1998 | EP0831864A1 Processed ginseng having enhanced pharmacological effect |
| 04/01/1998 | EP0831841A1 Means for treating radiation injuries |
| 04/01/1998 | EP0831836A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/01/1998 | EP0831833A1 Novel 5-cyclopropyl-1,4 benzodiazepine-2-ones |
| 04/01/1998 | EP0831831A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties |
| 04/01/1998 | EP0831830A1 Imidazole compounds |
| 04/01/1998 | EP0831822A1 Calcium channel antagonists |
| 04/01/1998 | EP0831817A1 Antigen-processing cell-targeted conjugates |
| 04/01/1998 | EP0831807A1 Use of brefeldin a and derivatives thereof in the treatment of hyperplasia and related disorders |
| 04/01/1998 | EP0831798A1 Use of selegiline to treat hearing loss in mammals |
| 04/01/1998 | EP0831771A2 Oral delivery of gene constructs |
| 04/01/1998 | EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
| 04/01/1998 | EP0625987B1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/01/1998 | EP0573510B1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 04/01/1998 | CN1177927A Extracts of shark cartilage, process of production and uses thereof |
| 03/31/1998 | US5734077 Antilipemic agents, anticholesterol agents, treatment of diabetes and atherosclerosis |
| 03/31/1998 | US5734051 8-substituted xanthine derivatives and method of use thereof |
| 03/31/1998 | US5733934 Antiarrythmic and cardioprotective substituted indenoylguanidines |
| 03/31/1998 | US5733931 Cyclohexanediurea derivative and process for its production |
| 03/31/1998 | US5733923 Secretory pancreatic phospholipase a2 |
| 03/31/1998 | US5733921 Isothiazolone compounds |
| 03/31/1998 | US5733913 Treating atherosclerosis, postsurgical restenosis |
| 03/31/1998 | US5733910 Pyridazinedione compounds useful in the treating neurological disorders |
| 03/31/1998 | US5733893 Binding of fibroblast growth factor to oligosaccharides |
| 03/31/1998 | US5733879 Peptides and proteins, process for their preparation and their use as cholesterol acceptors |
| 03/31/1998 | US5733876 Method of inhibiting angiogenesis |
| 03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 03/31/1998 | US5733869 Systemically administering stroma-free hemoglobin to a patient experiencing ventricular fibrillation during cardiac pulmonary resuscitation, and defibrillation to effect return of spontaneous cirulation in the patient |
| 03/31/1998 | CA2134889C Calcium channel blocking polypeptides from filistata hibernalis |
| 03/31/1998 | CA1339793C Cyclic analogs of atrial natriuretic peptides |
| 03/26/1998 | WO1998012334A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 03/26/1998 | WO1998012329A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
| 03/26/1998 | WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 03/26/1998 | WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 03/26/1998 | WO1998012194A1 Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient |
| 03/26/1998 | WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 03/26/1998 | WO1998011915A1 Strain selection of pneumococcal surface proteins |